After being absorbed by cancer cells, the miR-92 targets large tumor suppressor kinase 2 (LATS2) that interacts with Yes-associated protein 1 (YAP1) and regulates nuclear translocation of YAP1 in breast cancer cells. Here, YAP1 is linked to cancer.